Cabio Retained Earnings from 2010 to 2025

688089 Stock   19.70  0.15  0.77%   
Cabio Biotech's Retained Earnings are increasing over the years with slightly volatile fluctuation. Retained Earnings are expected to dwindle to about 291.8 M. Retained Earnings is the cumulative amount of net income that Cabio Biotech Wuhan retains for reinvestment in its operations, rather than distributing it to shareholders as dividends. View All Fundamentals
 
Retained Earnings  
First Reported
2019-06-30
Previous Quarter
448.6 M
Current Value
471.6 M
Quarterly Volatility
92.1 M
 
Covid
Check Cabio Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabio Biotech's main balance sheet or income statement drivers, such as Tax Provision of 17.8 M, Net Interest Income of 1.7 M or Interest Expense of 856.9 K, as well as many indicators such as . Cabio financial statements analysis is a perfect complement when working with Cabio Biotech Valuation or Volatility modules.
  
This module can also supplement various Cabio Biotech Technical models . Check out the analysis of Cabio Biotech Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Cabio Stock

Cabio Biotech financial ratios help investors to determine whether Cabio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cabio with respect to the benefits of owning Cabio Biotech security.